The Best of IMS

October 7 - November 4, 2026 - Webinar Series
The International Myeloma Society (IMS) is please to announce our “Best of IMS Series” a curated collection of the most significant insights and key breakthroughs from our annual meeting. This series of four webinars for our audiences in East Coast, West Coast, Europe, and Asia Pacific. 

 

 

8th Immune Effector Cell Therapies in Multiple Myeloma Workshop

March 19 - 20, 2027 - Boston Marriott Long Wharf, Boston, MA

Save the date for the 8th Immune Effector Cell Therapies in Multiple Myeloma Workshop – March 19-20, 2027.

More details will be released soon!

24th Annual Meeting & Exposition

September 29 - October 2, 2027 - New Delhi, India

Join us for the 24th International Myeloma Society (IMS) Annual Meeting in New Delhi, India, where the IMS will celebrate 40 years of advancing myeloma research and care.

 

 

More details will be shared soon.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated